MedPath

Comparsion of SPARK and Fundamental Motor Training

Not Applicable
Completed
Conditions
Autism Spectrum Disorder
Registration Number
NCT05986760
Lead Sponsor
khadija liaquat
Brief Summary

It was a Randomized Clinical Trial.Data will be collected from Life care rehabilitation and special child facility.The study was completed within 6 months after approval of synopsis.The

calculated sample size, through WHO sample size calculator, using Bruininks- Oseretsky test's mean and standard deviation (Mean Dynamic Balance) as outcome

measure was 20 in each group. After adding 10% dropout the sample size will be 20+4=24 in each group; hence, overall sample size n= 20. Age range 5-12 years. Children with diagnosed Autism and age ranges between 5-12 will be included in the study.Convenient Sampling Technique was used to collect the data.There was two groups.In Group A SPARK therapy will be provided and in group 2 fundamental motor skill training will be provided. To assess the social skills Gilliam Autism Rating Scale-Second Edition (GARS-2) and for motor skills Bruininkse Oseretsky test of motor proficiency (BOTMP) was used.

Detailed Description

Autism Spectrum Disorder affects the social communication and fundamental motor skills of children. The current study will evaluate the effects of sports play and active recreation for kids (SPARK) versus fundamental motor skill training on social and motor skills in children with Autism spectrum disorder. It was a Randomized Clinical Trial.Data will be collected from Life care rehabilitation and special child facility.The study was completed within 6 months after approval of synopsis.The

calculated sample size, through WHO sample size calculator, using Bruininks- Oseretsky test's mean and standard deviation (Mean Dynamic Balance) as outcome

measure was 20 in each group. After adding 10% dropout the sample size will be 20+4=24 in each group; hence, overall sample size n= 20. Age range 5-12 years. Children with diagnosed Autism and age ranges between 5-12 will be included in the study.Convenient Sampling Technique was used to collect the data.There was two groups.In Group A SPARK therapy will be provided and in group 2 fundamental motor skill training will be provided. To assess the social skills Gilliam Autism Rating Scale-Second Edition (GARS-2) and for motor skills Bruininkse Oseretsky test of motor proficiency (BOTMP) was used. Analysis was carried out on SPSS version 27.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18
Inclusion Criteria
  • Age range 5-9 years (11) • Diagnosed with an Autism Spectrum Disorder (ASD) based on Diagnostic and

Statistical Manual of Mental Disorders,

  • Pervasive developmental disorder-not otherwise specified
  • Asperger's disorder based on clinical judgment and supported by the Autism Diagnostic Observation Schedule
  • Having moderate or greater behavioral problems as measured by a pretreatment score of >15 on the Aberrant Behavior Checklist-Irritability subscale
  • Ability to follow directions and perform requested motor skill proficiency and executive function measures
Exclusion Criteria
  • Participants with diagnosed cognitive impairments

    • Unable to walk independently
    • History of traumatic injury
    • History of previous surgery history
    • Inability to understand the procedure and unwillingness to participate

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Social skillsAssessment took at 0 week of intervention and final reading was taken on 10th week of intervention

Gilliam Autism Rating Scale-Second Edition (GARS-2)

Motor Skills:Assessment took at 0 week of intervention and final reading was taken on 10th week of intervention

Bruininkse Oseretsky test of motor proficiency (BOTMP)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Riphah Rehabilitation Center

🇵🇰

Lahore, Punjab, Pakistan

Riphah Rehabilitation Center
🇵🇰Lahore, Punjab, Pakistan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.